Eric d'Esparbes
2021 - BIORA THERAPEUTICS
Compensation breakdown
Non-Equity Incentive Plan | $130,000 |
---|---|
Option Awards | $555,478 |
Salary | $471,635 |
Stock Awards | $420,733 |
Other | $17,670 |
Total | $1,595,516 |
d'Esparbes received $555.5K in option awards, accounting for 35% of the total pay in 2021.
d'Esparbes also received $130K in non-equity incentive plan, $471.6K in salary, $420.7K in stock awards and $17.7K in other compensation.
Rankings
In 2021, Eric d'Esparbes' compensation ranked 6,991st out of 12,415 executives tracked by ExecPay. In other words, d'Esparbes earned more than 43.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,991 | 44th |
Manufacturing | 3,062 | 44th |
Chemicals And Allied Products | 1,356 | 43rd |
Drugs | 1,209 | 42nd |
Pharmaceutical Preparations | 881 | 43rd |
d'Esparbes' colleagues
We found six more compensation records of executives who worked with Eric d'Esparbes at BIORA THERAPEUTICS in 2021.
2021
Adi Mohanty
BIORA THERAPEUTICS
Chief Executive Officer
2021
Harry Stylli
BIORA THERAPEUTICS
Chief Executive Officer
2021
Clarke Neumann
BIORA THERAPEUTICS
General Counsel
2021
Matthew Cooper
BIORA THERAPEUTICS
Chief Scientific Officer
2021
Sami Shihabi
BIORA THERAPEUTICS
Former Chief Commercial Officer
2021
Hutan Hashemi
BIORA THERAPEUTICS
Former Chief Compliance Officer
News
April 24, 2024
April 27, 2023
April 28, 2022
April 15, 2021
March 13, 2019